Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4 + and CD8 + T cells

Abstract

Purpose: The sperm-derived SPANX family proteins can be found expressed in human tumors. Here, we aimed to perform a comprehensive study to evaluate immunotherapeutic relevance of one of its members, SPANX-B. We wanted to test its expression pattern in human tumors and to evaluate CD4 + and CD8 + T-cell responses in healthy humans after in vitro immunizations. Experimental Design: Expression of SPANX-B in human malignancies, including a multitumor tissue array of 145 primary tumors, was assessed using reverse transcription-PCR, Western blotting, and immunohistochemical analysis. T-cell immunogenicity and immunodominant epitopes of SPANX-B were studied using in vitro immunizations of healthy human donor-derived leukocytes. Results: SPANX-B was abundantly expressed in melanoma and carcinomas of lung, ovary, colon, and breast. In melanoma, tissue array data indicated that it was expressed in advanced and metastatic disease. Unlike most tumor-associated antigens, SPANX-B was an immunogenic antigen that was recognized by circulating T-cell precursors in healthy humans. Importantly, theseT cells were readily expanded to generate SPANX-B-specific helper CD4 + and cytolytic CD8 + T cells that recognized unique immunodominant epitopes: at least one HLA-DR-restricted Pep-9 epitope (SPANX-B 12-23) and two HLA-A2-restricted Pep-2 and Pep-4 epitopes (SPANX-B 23-31 and SPANX-B 57-65, respectively). CD8 + Tcells were fully functional to recognize and lyse HLA- A2-expressing tumors, including primary human melanomas.Conclusions: SPANX-B is an immunogenic sperm-derived antigen that is expressed in several human tumors. SPANX-B is also efficiently recognized by the humanT-cell immune arm, indicating its significant value for the development of protective and therapeutic cancer vaccines. © 2009 American Association for Cancer Research.